Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long Term Dosing of Romiplostim in Japanese ITP Extension Study
NCT00440037Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Nov 2006
- Primary completion
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of romiplostim in immune thrombocytopenia (ITP), sponsored by Kyowa Kirin. Started Nov 2006; status: completed.
02
Drugs
romiplostim
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT00440037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440037.